|
MED23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93001170600837E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.39009956060477E-11 |
| Normal-vs-Stage2 |
1.90660000010112E-07 |
| Normal-vs-Stage3 |
8.50097769955482E-13 |
| Normal-vs-Stage4 |
1.55379999977612E-08 |
| Stage1-vs-Stage2 |
3.398200E-01 |
| Stage1-vs-Stage3 |
1.802010E-02 |
| Stage1-vs-Stage4 |
8.417800E-02 |
| Stage2-vs-Stage3 |
4.954200E-01 |
| Stage2-vs-Stage4 |
4.814000E-01 |
| Stage3-vs-Stage4 |
8.193000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.1601392309949E-14 |
| Normal-vs-AfricanAmerican |
4.402000E-04 |
| Normal-vs-Asian |
3.65500000000241E-05 |
| Caucasian-vs-AfricanAmerican |
3.627400E-01 |
| Caucasian-vs-Asian |
1.433390E-01 |
| AfricanAmerican-vs-Asian |
8.809600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.54940002442083E-09 |
| Normal-vs-Female |
1.90336635341737E-12 |
| Male-vs-Female |
9.716400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.22270005231684E-09 |
| Normal-vs-Age(41-60Yrs) |
9.22062426411685E-12 |
| Normal-vs-Age(61-80Yrs) |
2.56749954630209E-10 |
| Normal-vs-Age(81-100Yrs) |
2.765200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.145500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.090000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.744960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.004800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.407800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.524000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.320800E-03 |
| Classical-VS-Follicular |
3.965200E-01 |
| Classical-VS-Other |
8.780600E-01 |
| Classical-VS-Normal |
6.15110185009371E-11 |
| Tall-VS-Follicular |
9.200200E-02 |
| Tall-VS-Other |
3.040400E-01 |
| Tall-VS-Normal |
8.22729662175448E-11 |
| Follicular-VS-Other |
6.958400E-01 |
| Follicular-VS-Normal |
6.09200000445398E-08 |
| Other-VS-Normal |
2.998100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89169790942856E-11 |
| Normal-vs-N1 |
3.7338999999692E-06 |
| N0-vs-N1 |
4.667400E-01 |
|
|
